retatrutide weight loss trial results news This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far Retatrutide phase 3 obesity trial

Key takeaways Yes, Lexapro is FDA-approved to treat generalized anxiety disorder and can also help with panic disorder and social anxiety

The itch in eczema is not primarily histamine-mediated, which is why antihistamines generally provide poor relief

haha Bryce Platt, PharmD Behavior follows the commercials

Resmetirom (Rezdiffra TM ), a liver-directed thyroid hormone receptor- (THR-) agonist, received accelerated FDA approval in March 2024 as the first agent specifically indicated for non-cirrhotic MASH with moderate-to-advanced fibrosis (F2-F3), based on the MAESTRO-NASH trial demonstrating MASH resolution and fibrosis improvement

Additional investigations have examined its role in xenobiotic metabolism, heavy metal chelation, and immune cell function modulation